Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,816 | 22,088 | 30,451 | 27,702 | 27,132 |
| Marketable Securities | 915 | 627 | 903 | 619 | 829 |
| Receivables | 3,013 | 1,157 | 1,719 | 939 | 2,068 |
| TOTAL | $29,257 | $25,649 | $35,152 | $31,047 | $32,907 |
| Non-Current Assets | |||||
| PPE Net | 4,992 | 5,529 | 4,726 | 4,062 | 8,932 |
| Investments And Advances | 161,254 | 100,039 | 95,692 | 56,532 | 4,436 |
| Intangibles | 8,646 | 10,206 | 10,848 | 11,491 | 32,278 |
| Other Non-Current Assets | 1,067 | 1,149 | 1,156 | 1,195 | 1,561 |
| TOTAL | $175,959 | $116,923 | $112,422 | $73,280 | $47,207 |
| Total Assets | $205,216 | $142,572 | $147,574 | $104,327 | $80,114 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,947 | 7,144 | 7,176 | 6,508 | 10,674 |
| TOTAL | $8,820 | $8,850 | $8,338 | $7,403 | $13,669 |
| Non-Current Liabilities | |||||
| Long Term Debt | 95 | 120 | 173 | 173 | 220 |
| Deferred Revenues | 679 | 572 | 537 | 627 | 2,878 |
| Other Non-Current Liabilities | 4,694 | 5,234 | 4,236 | 5,411 | 12,687 |
| TOTAL | $6,699 | $3,214 | $2,995 | $2,872 | $6,853 |
| Total Liabilities | $15,519 | $12,064 | $11,333 | $10,275 | $20,522 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 110,876 | 110,854 | 103,392 | 103,392 | 94,962 |
| Common Shares | 333,997 | 317,878 | 313,506 | 310,881 | 275,238 |
| Retained earnings | -147,033 | -196,321 | -190,534 | -221,743 | -246,293 |
| Other shareholders' equity | 2,733 | 11,951 | 16,269 | 7,914 | 48,647 |
| TOTAL | $189,697 | $130,508 | $136,241 | $94,052 | $59,592 |
| Total Liabilities And Equity | $205,216 | $142,572 | $147,574 | $104,327 | $80,114 |